vimarsana.com

Page 6 - மயோ சிகிச்சையகம் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Leukemia & Lymphoma Society Launches Impact Research Grants To Help Underserved Patients Access Clinical Trials

The Leukemia & Lymphoma Society Launches Impact Research Grants To Help Underserved Patients Access Clinical Trials Collaborations with Mayo Clinic, Vanderbilt University Medical Center and Weill Cornell Medicine will Increase Representation of Geographically, Ethnically and Economically Underserved Communities in Clinical Trials News provided by Share this article RYE BROOK, N.Y., May 13, 2021 /PRNewswire/ The Leukemia & Lymphoma Society (LLS) announced today the launch of the IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants to increase enrollment of individuals from underrepresented communities in clinical trials. Clinical trials are vital to improving cancer treatment, giving newly diagnosed patients access to state-of-the-art therapies, and providing a lifeline when other treatments have failed. Yet, clinical trials overwhelmingly fail to represent certain patient populations such as ethnic and racial minorities and people in rural co

The Leukemia & Lymphoma Society Launches IMPACT Research Grants to Help Underserved Patients Access Clinical Trials

Press release content from PR Newswire. The AP news staff was not involved in its creation. The Leukemia & Lymphoma Society Launches IMPACT Research Grants to Help Underserved Patients Access Clinical Trials May 6, 2021 GMT RYE BROOK, N.Y., May 6, 2021 /PRNewswire/ The Leukemia & Lymphoma Society (LLS) announced today the launch of the IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants to increase enrollment of individuals from underrepresented communities in clinical trials. Clinical trials are vital to improving cancer treatment, giving newly diagnosed patients access to state-of-the-art therapies, and providing a lifeline when other treatments have failed. Yet, clinical trials overwhelmingly fail to represent certain patient populations such as ethnic and racial minorities and people in rural communities.

NCCN Releases New Patient Guidelines on Anemia and Neutropenia

NCCN Releases New Patient Guidelines on Anemia and Neutropenia NCCN.org/patientguidelines (NCCN : Anemia and Neutropenia, Low Red and White Blood Cell Counts funded by the NCCN Foundation and endorsed by The Leukemia and Lymphoma Society (LLS). The free information source is designed to help people living with cancer and caregivers recognize symptoms of blood cell deficiencies caused by cancer or chemotherapy-and increase engagement with their oncology care team about management and support. Chemotherapy and certain cancers can slow the body s production of red blood cells (which carry oxygen), platelets (which help stop bleeding by forming blood clots) and white blood cells (which help protect against infection). Anemia, a deficiency of red blood cells, can cause tiredness and headaches, while neutropenia and thrombocytopenia-a shortage of white blood cells and platelets, respectively-often go unnoticed before reaching severely low levels. Yet all three conditions can cause da

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.